Clinical Trials in Brazil / NCT07224646
Recruiting Not applicable

Whole-Body Photobiomodulation Use in Professional Soccer Players During a State Championship

NCT07224646 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-09-04
Last updated
2025-11-24

Condition(s) studied

Athletic PerformanceMuscle FatigueMuscle StrengthSports

Investigational drug(s) / intervention(s)

Whole-Body Photobiomodulation (PBM) (Active PBM)Sham PBM

Whole-Body Photobiomodulation (PBM) (Active PBM): This intervention consists of whole-body photobiomodulation delivered using a full-body PBM device. Sessions are performed twice weekly on non-consecutive days for 8 weeks, coinciding with the athletes' standard training. The device emits therapeutic light at specified wavelengths and power, targeting the entire body. The protocol is standardized according to prior research, ensuring consistent exposure for all participants in the active arm. The intervention aims to improve muscle performance and recovery while reducing delayed onset muscle soreness (DOMS).

Sham PBM: Intervention Description (Sham PBM): Participants receive a sham photobiomodulation intervention using the same device and schedule, but without emission of therapeutic light. The procedure mimics the active intervention to maintain blinding while allowing comparison of outcomes, including muscle performance, DOMS, and blood markers.

Study summary

This study aims to investigate the effects of whole-body photobiomodulation on professional soccer players during a state championship. The primary question is whether photobiomodulation improves recovery, reduces muscle fatigue, and enhances performance compared to standard training without photobiomodulation.

Eligibility

Sex
MALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Male professional soccer players currently competing in the championship * Age 18-35 years * Training frequency ≥5 times per week * Able to attend all PBM/sham sessions and all assessments during the 8-week intervention * Signed informed consent Exclusion Criteria: * Lower-limb musculoskeletal injury in the last 6 months or currently receiving treatment * Current use of phototherapy or any other recovery-enhancing modality * Chronic medical conditions that may affect performance or recovery * Known sensitivity or contraindication to light-based therapies * Inability to comply with the intervention or training schedule

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Desportivo Brasil Training Center Porto Feliz São Paulo Recruiting

More Universidade Federal de Sao Carlos trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07224646 on ClinicalTrials.gov ↗ ← All trials in Brazil